CoChat

Skin Cancer in Heart Transplant Recipients : Risk Factor Analysis and Relevance of Immunosuppressive Therapy

Caforio, A. L. P., Fortina, A. B., Piaserico, S., Alaibac, M., Tona, F., Feltrin, G., Pompei, E., Testolin, L., Gambino, A., Volta, S. D., Thiene, G., Casarotto, D., Peserico, A. · 2000 · Circulation
Cited by 149

The DOI matches its Crossref record.

Abstract

BACKGROUND: The frequency of skin tumors of all types and specifically of squamous cell carcinoma (SCC) is increased in heart transplantation (HT), but the predisposing risk factors are controversial. METHODS AND RESULTS: We studied 300 patients (age 49+/-15 years, 258 men, mean follow-up 4.6 years, follow-up range 1 month to 12 years) who were receiving standard double (cyclosporin plus azathioprine) or triple (cyclosporin plus azathioprine plus prednisone) therapy. The first-year rejection score was calculated for endomyocardial biopsy samples (International Society for Heart and Lung Transplantation grade 0=0, 1A=1, 1B=2, 2=3, 3A=4, 3B=5, and 4=6) and used as an indirect marker of the level of immunosuppression. Multivariate analysis (Cox regression) included age at HT, sex, skin type, first-year rejection score, presence of warts and solar keratosis, lifetime sunlight exposure, and first-year cumulative dose of steroids. The incidence of skin tumors of all types increased from 15% after 5 years to 35% after 10 years after HT according to life-table analysis. Age at HT of >50 years (P:=0.03, RR=5.3), skin type II (P:=0.05, RR=2.6), rejection score of 19 (P:=0.003, RR=5.7), solar keratosis (P:=0.001, RR=6.9), and lifetime sunlight exposure of >30 000 hours (P:=0.0003, RR=7.6) were risk factors for SCC. CONCLUSIONS: Older age at HT, light skin type, solar keratosis, greater sunlight exposure, and high rejection score in the first year were independently associated with an increased risk of SCC. The progressive increase in cancer frequency during follow-up and the association with high rejection scores suggest that both the length and level of immunosuppression may be relevant. Because cumulative immunosuppressive load is cumbersome to calculate, a high rejection score in the first year may provide a useful predictor for patients at risk.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.cir.102.suppl_3.iii-222

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 149

Metadata

Authors
Caforio, A. L. P., Fortina, A. B., Piaserico, S., Alaibac, M., Tona, F., Feltrin, G., Pompei, E., Testolin, L., Gambino, A., Volta, S. D., Thiene, G., Casarotto, D., & Peserico, A.
Venue
Circulation
Published
2000-11-07
Volume
102
Issue
Supplement 3
Pages
III-222-III-227
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W1975936023
Cited by
149
References
0
FWCI
3.86
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Skin Cancer in Heart Transplant Recipients : Risk Factor Analysis and Relevance of Immunosuppressive Therapy. https://app.cochat.ai/papers/10.1161/01.cir.102.suppl_3.iii-222
The paper
Caforio, A. L. P., Fortina, A. B., Piaserico, S., Alaibac, M., Tona, F., Feltrin, G., Pompei, E., Testolin, L., Gambino, A., Volta, S. D., Thiene, G., Casarotto, D., & Peserico, A. (2000). Skin Cancer in Heart Transplant Recipients : Risk Factor Analysis and Relevance of Immunosuppressive Therapy. Circulation. https://doi.org/10.1161/01.cir.102.suppl_3.iii-222

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.